CommercialCoverageMedium impact
08.02.38, Zenocutuzumab-zbco (Bizengri®)
Independence Blue Cross·Oncology, Pharmacy·Pharmacy
Effective date
Jul 28, 2025
We identified it
Jun 19, 2026
Summary
This is a new pharmacy policy establishing coverage criteria for Zenocutuzumab-zbco (Bizengri®), a new biologic medication. The billing team must implement this policy in their system to ensure proper claim submission and reimbursement for this newly covered drug effective immediately.
Action Required
By 2025-07-28: Pharmacy billing team must add HCPCS code J9279 (Zenocutuzumab-zbco injection) to the billing system and update formulary/coverage tables. Configure the system to process claims for this new biologic medication and communicate coverage details to dispensing pharmacies and prescribing providers. Ensure prior authorization workflows are established if required by the policy. Verify claim submission processes align with the new policy guidance. Failure to implement may result in claim denials or processing delays for this newly covered medication.